Selected article for: "current state and health threat"

Author: Jin, Yuefei; Yang, Haiyan; Ji, Wangquan; Wu, Weidong; Chen, Shuaiyin; Zhang, Weiguo; Duan, Guangcai
Title: Virology, Epidemiology, Pathogenesis, and Control of COVID-19
  • Cord-id: ejg6hpuy
  • Document date: 2020_3_27
  • ID: ejg6hpuy
    Snippet: The outbreak of emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) in China has been brought to global attention and declared a pandemic by the World Health Organization (WHO) on March 11, 2020. Scientific advancements since the pandemic of severe acute respiratory syndrome (SARS) in 2002~2003 and Middle East respiratory syndrome (MERS) in 2012 have accelerated our understanding of the epidemiology and pathogenesis of SARS-CoV-2 and the development of therap
    Document: The outbreak of emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) in China has been brought to global attention and declared a pandemic by the World Health Organization (WHO) on March 11, 2020. Scientific advancements since the pandemic of severe acute respiratory syndrome (SARS) in 2002~2003 and Middle East respiratory syndrome (MERS) in 2012 have accelerated our understanding of the epidemiology and pathogenesis of SARS-CoV-2 and the development of therapeutics to treat viral infection. As no specific therapeutics and vaccines are available for disease control, the epidemic of COVID-19 is posing a great threat for global public health. To provide a comprehensive summary to public health authorities and potential readers worldwide, we detail the present understanding of COVID-19 and introduce the current state of development of measures in this review.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and ade antibody dependent enhancement: 1, 2
    • acute ards respiratory distress syndrome and ade dependent enhancement: 1, 2
    • acute ards respiratory distress syndrome and ade dependent enhancement antibody: 1, 2
    • acute ards respiratory distress syndrome and admission icu patient: 1
    • acute lung injury and ade antibody dependent enhancement: 1
    • acute lung injury and ade dependent enhancement: 1
    • acute lung injury and ade dependent enhancement antibody: 1
    • acute respiratory distress syndrome and ade antibody dependent enhancement: 1, 2, 3, 4
    • acute respiratory distress syndrome and ade dependent enhancement: 1, 2, 3, 4
    • acute respiratory distress syndrome and ade dependent enhancement antibody: 1, 2, 3, 4
    • acute respiratory distress syndrome and admission icu patient: 1, 2, 3, 4